SCHEMBL9830002

SCHEMBL9830002

CC1CCN(Cl)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10531422 0.89
SCHEMBL17934318 0.81
SCHEMBL8234341 0.81
SCHEMBL1742203 0.73
SCHEMBL1629925 0.72 PHGDH (0.42)
SCHEMBL14573053 0.69 CARM1 (0.44)
SCHEMBL13400 0.69
SCHEMBL1109080 0.69
SCHEMBL3336982 0.67
SCHEMBL13750467 0.67 CYP2D6 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3700911-B1 NOVEL MACROCYCLIC DERIVATIVES, PROCESS FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SERVIER LAB (FR) 2023-09-06 EP disclosed
US-20180042902-A1 Heterocyclic Compounds and Uses Thereof INTELLIKINE, LLC 2018-02-15 US disclosed
US-9682141-B2 Combination of kinase inhibitors and uses thereof INTELLIKINE LLC (US) 2017-06-20 US disclosed
EP-2288601-B1 BICYCLYLARYL-ARYL-AMINE COMPOUNDS AND THEIR USE CANCER REC TECH LTD (GB) 2014-10-15 EP disclosed
WO-2009126535-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2009-10-15 WO disclosed
EP-0307303-B1 1-[(2-Pyrimidinyl)-aminoalkyl] piperidines, their preparation and their use in therapy SYNTHELABO (FR) 1991-12-04 EP disclosed
EP-0307303-A1 1-[(2-Pyrimidinyl)-aminoalkyl] piperidines, their preparation and their use in therapy SYNTHELABO (FR) 1989-03-15 EP disclosed